Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
JAZZ After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.39%168.950.4%$364.97m
VRXValeant Pharmaceuticals International, Inc.
-0.32%22.0714.1%$216.52m
PRGOPerrigo Co. Plc
-0.70%75.686.7%$103.03m
JAZZJazz Pharmaceuticals Plc
-0.87%166.052.2%$88.19m
PTLAPortola Pharmaceuticals, Inc.
-0.99%40.957.7%$80.44m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.78%151.947.6%$74.18m
SAGESAGE Therapeutics, Inc.
-0.71%163.099.6%$72.00m
MNKMallinckrodt Plc
1.15%15.8821.1%$56.75m
SUPNSupernus Pharmaceuticals, Inc.
-1.96%55.006.3%$47.51m
UTHRUnited Therapeutics Corporation
-2.02%104.1214.4%$39.48m
PBHPrestige Brands Holdings, Inc.
-1.34%33.843.8%$39.02m
ICPTIntercept Pharmaceuticals, Inc.
-3.22%70.1221.8%$34.58m
CTLTCatalent Inc
0.42%40.392.6%$32.36m
HZNPHorizon Pharma plc
-0.66%15.017.5%$29.57m
ENDPEndo International Plc
-2.13%5.978.9%$27.78m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.